<DOC>
	<DOCNO>NCT00148213</DOCNO>
	<brief_summary>Human thyroglobulin ( Tg ) sensitive biochemical marker recurrence differentiate cancer ( DTC ) , especially complete removal thyroid tissue surgery radioiodine therapy ( RIT ) . Unfortunately , current assay measure Tg blood sample sensitive enough reliably measure Tg patient thyroid hormone replacement therapy . Instead patient withdraw thyroid hormone several week receive costly injection recombinant thyroid stimulate hormone ( TSH ) order raise Tg production thyroid remnant and/or thyroid cancer cell measure current Tg assay . Other patient antibody Tg interfere current immunoassay . The purpose study characterize new highly sensitive assay measure Tg serum thyroid cancer patient thyroid hormone therapy therapy comparison normal routine assay already use Münster University Hospital .</brief_summary>
	<brief_title>Clinical Evaluation New Highly Sensitive Thyroglobulin Assay Differentiated Thyroid Carcinoma</brief_title>
	<detailed_description>Sera 100 consecutive DTC patient total thyroidectomy collect Department Nuclear Medicine TSH-suppression therapy endogenous TSH stimulation ( TSH &gt; 25 mU/l ) . All patient stag clinical examination , cervical ultrasound ( 7.5 MHz ) , I-131 whole-body scintigraphy – applicable – F18-FDG-PET . Written inform consent obtain pt . Sera take separation tube without anticoagulant store -20°C analysis . Sera allow come room temperature prior analysis . Tg , TgR TgAb concentration determine fully automate two-site chemiluminescence immunoassay ( CLIA ; Nichols Advantage® ; Nichols Institute Diagnostics , San Clemente , California ) . All 3 assay base identical highly purified hTg material calibration ( Tg ) , recovery ( TgR ) antigen ( TgAb ; biotinylated acridinium ester label ) optimum comparability test result . In addition , Tg TgR measure fully automate two-site TRACE immunoassay ( BRAHMS Kryptor® , Brahms AG , Hennigsdorf , Germany ) TSH 3rd-generation CLIA assay ( TSH-3 , Advia Centaur , Bayer Corporation ) .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Thyroid Diseases</mesh_term>
	<mesh_term>Thyroid Neoplasms</mesh_term>
	<criteria>histological diagnosis differentiate thyroid carcinoma total near total thyroidectomy inform consent inform consent</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>differentiate thyroid carcinoma</keyword>
	<keyword>thyroglobulin</keyword>
	<keyword>immunoassay</keyword>
	<keyword>thyroidectomy</keyword>
	<keyword>radioiodine therapy</keyword>
</DOC>